Then, in recent years, Massoth et al. [82] demonstrated the presence of KMT2A-MAML2 gene fusion in up to 6% of type B2 and B3 thymomas, which is instead absent among type A, AB, B1 thymomas, and thymic carcinomas. Here, KMT2A is linked to thymoma.